Pharmacokinetics, metabolism, distribution and permeability of nanomedicine

S Ravindran, JK Suthar, R Rokade… - Current drug …, 2018 - ingentaconnect.com
Background: Medical application of nanotechnology is termed as Nanomedicine and is
widely used in healthcare industries. Nanotechnology has helped Physicians, Scientists and …

Modeling reactivity to biological macromolecules with a deep multitask network

TB Hughes, NL Dang, GP Miller… - ACS central …, 2016 - ACS Publications
Most small-molecule drug candidates fail before entering the market, frequently because of
unexpected toxicity. Often, toxicity is detected only late in drug development, because many …

Nanomedicine: Bioavailability, biotransformation and biokinetics

S Ravindran, AJ Tambe, JK Suthar… - Current drug …, 2019 - ingentaconnect.com
Background: Nanomedicine is increasingly used to treat various ailments. Biocompatibility of
nanomedicine is primarily governed by its properties such as bioavailability …

Metabolomics reveals the formation of aldehydes and iminium in gefitinib metabolism

X Liu, Y Lu, X Guan, B Dong, H Chavan, J Wang… - Biochemical …, 2015 - Elsevier
Gefitinib (GEF), an inhibitor of epidermal growth factor receptor (EGFR) tyrosine kinase, is
widely used for the treatment of cancers, particularly non-small cell lung cancer. However, its …

[图书][B] Cytochrome P450 2D6: structure, function, regulation and polymorphism

S Zhou - 2018 - taylorfrancis.com
Cytochromes are proteins that catalyze electron transfer reactions of well-known metabolic
pathways and are classified in various superfamilies. The CYP, or P450, superfamily …

Modeling the bioactivation and subsequent reactivity of drugs

TB Hughes, N Flynn, NL Dang… - Chemical research in …, 2021 - ACS Publications
Electrophilically reactive drug metabolites are implicated in many adverse drug reactions. In
this mechanism—termed bioactivation—metabolic enzymes convert drugs into reactive …

[HTML][HTML] Pharmacokinetics of intravenous pan-class I phosphatidylinositol 3-kinase (PI3K) inhibitor [14C]copanlisib (BAY 80-6946) in a mass balance study in healthy …

M Gerisch, T Schwarz, D Lang, G Rohde, S Reif… - Cancer Chemotherapy …, 2017 - Springer
Purpose To determine the pharmacokinetics of radiolabeled copanlisib (BAY 80-6946) in
healthy male volunteers and to investigate the disposition and biotransformation of …

Microbioreactors and perfusion bioreactors for microbial and mammalian cell culture

S Ravindran, P Singh, S Nene, V Rale… - Biotechnology and …, 2019 - books.google.com
Screening for novel producer strains and enhanced therapeutic production at reduced cost
has been the focus of most of the biopharmaceutical industries. The obligation to carry out …

Technologies and strategies to characterize and quantitate metabolites in drug discovery and development

S Ravindran, A Jadhav, P Surve… - Biomedical …, 2014 - Wiley Online Library
Pharmacokinetics and toxicokinetics studies rely on the quantitation of drugs and its
metabolites. Drug metabolism studies are based on the characterization of the structure of …

In vitro biotransformation in drug discovery

S Ravindran, R Rokade, J Suthar, P Singh… - Concepts to …, 2018 - books.google.com
In vitro Biotransformation studies play a crucial role in drug discovery program that
determine the fate of the new chemical entities (NCE's). Enzyme rich matrices such as …